← All Authorities
Singapore
patent linkageregulatory
Millennium Pharmaceuticals Inc v Drug Houses of Australia Pte Ltd
[2019] SGCA 31; [2019] 2 SLR 1017
Key Principle
The Court of Appeal held that, under Singapore's patent-linkage regime, a process (manufacturing) patent can be a 'patent in respect of the therapeutic product' that a generic applicant must declare to the Health Sciences Authority, so the term 'patent' is not confined to product patents.
Area of Law
ip
Related Cases